Milwaukee County v. D. H.

COURT OF APPEALS
DECISION NOTICE
DATED AND FILED This opinion is subject to further editing. If
published, the official version will appear in
the bound volume of the Official Reports.
March 7, 2023
A party may file with the Supreme Court a
Sheila T. Reiff petition to review an adverse decision by the
Clerk of Court of Appeals Court of Appeals. See WIS. STAT. § 808.10
and RULE 809.62.

Appeal No. 2022AP1402 Cir. Ct. No. 2017ME72

STATE OF WISCONSIN IN COURT OF APPEALS
DISTRICT I

IN THE MATTER OF THE MENTAL COMMITMENT OF D. H.

MILWAUKEE COUNTY,

PETITIONER-RESPONDENT,

V.

D. H.,

RESPONDENT-APPELLANT.

APPEAL from an order of the circuit court for Milwaukee County:
LINDSEY CANONIE GRADY, Judge. Reversed and cause remanded with
directions.
No. 2022AP1402

¶1 WHITE, J.1 Dan appeals from the circuit court order granting
Milwaukee County’s request for involuntary medication and treatment.2 Dan
argues that the County failed to satisfy its burden to prove that the County’s
medical expert witness had given the patient a reasonable explanation of the
advantages and disadvantages, side effects, and alternatives to the prescribed
involuntary medications and treatment. Upon review, we conclude that the
County failed to satisfy its burden; therefore, the circuit court’s order was
erroneously granted. Accordingly, we reverse the order and remand with
directions to vacate the medication order.3

BACKGROUND

¶2 This case arises out of the latest extension of Dan’s involuntary
medication and treatment order in December 2021. The County’s petitions for
commitment and involuntary medication had been granted by the circuit court in
2017, 2018, 2019, and 2020.4 In 2017, the circuit court found Dan incompetent to
proceed to trial on a second-degree sexual assault charge in April 2016. Dan had
been admitted to Mendota Mental Health Institute, where he is still housed, for

1
This appeal is decided by one judge pursuant to WIS. STAT. § 752.31(2)(d) (2021-22).

All references to the Wisconsin Statutes are to the 2021-22 version unless otherwise
noted.
2
For ease of reading, we refer to D.H. by a pseudonym. See WIS. STAT. RULE 809.86.
3
During the pendency of these proceedings, we granted the County’s request for an
extension of time to respond to Dan’s appeal. As a result, the medication order appears to have
expired. The issue of mootness has not been raised by the parties and we do not address it.
4
The Honorable Lindsey Canonie Grady granted the order for involuntary medication
and treatment in 2021. Multiple judges have ruled on various decisions regarding Dan’s
treatment since 2016; we refer to all of them generally as the circuit court unless noted.

2
No. 2022AP1402

treatment of his competency to proceed to trial, pursuant to WIS. STAT.
§ 971.14(5). However, Dan’s case was converted to a civil commitment
proceeding pursuant to § 971.14(6) on the basis that Dan was incompetent to stand
trial and was unlikely to become competent within the remaining commitment
period under ch. 971.

¶3 On December 3, 2021, the trial court heard the County’s petition to
extend Dan’s civil commitment for an additional twelve months. 5 In the signed
court order, the trial court found that Dan was mentally ill, dangerous due to “a
substantial probability of physical harm to other individuals,” and that based on
Dan’s treatment record, there was a substantial likelihood that that Dan would be a
proper subject for commitment if treatment were withdrawn.

¶4 Approximately two weeks later, the circuit court addressed the
County’s petition for involuntary medication and treatment. The record reflects
that in the December 17, 2021 hearing, Dr. Odette Anderson testified about Dan’s
“schizoaffective disorder,” which was exhibited by “irritable mood, agitated mood
at times, grandiosity in his thinking, expansive mood at times. Mood lability,
meaning that he will switch from feeling agitated and angry to sad, depressed to
on top of the world, unstoppable, euphoric.”

¶5 Dr. Anderson then testified about the Dan’s treatment plan including
prescribed medications:

5
The Honorable Paul R. Van Grunsven presided over the 2021 commitment extension
hearing and issued that order; however, Dan’s case was moved to Judge Lindsey Canonie Grady
between the commitment and involuntary medication hearings. We refer to Judge Van Grunsven
as the trial court.

3
No. 2022AP1402

He takes Risperidone, which is an anti-psychotic
medication aimed at the psychotic piece of the illness. He
takes Sertraline to decrease his tendency towards sexually
inappropriate behaviors. He takes valproic acid, which
helps specifically with mood stabilization. He takes
Lorazepam to address anxiety and also to augment the
effects of the anti-psychotic Risperidone.

He takes Escitalopram to help with some of the anxieties,
specifically aimed at his frequent thoughts and distress
about wanting to leave Mendota Mental Health Institute but
not being able to do so. And finally he takes Benztropine,
which is a medication aimed at prophylaxis or prevention
of side effects, for which [Dan] has a high risk of
developing given that he is taking Risperidone.

The County asked if the medication each had an “an injectable alternative,” to
which Dr. Anderson replied that “[n]ot each of them in terms of an exact
alternative of the medicine,” but she employed Haloperidol as a substitute.

¶6 Dr. Anderson testified that prior to submitting the petition for
medication, she spoke with Dan about the medication prescribed, the benefits,
risks, and alternative psychotropic medications. The doctor stated she told Dan
about the medications in two parts:

One we talked about is the benefits in terms of the
biological effects of the drugs and how they will affect the
symptoms of his schizoaffective disorder that he has. The
other approach that we take, we explain this to [Dan], is to
speak to goals that he has shared with us, namely that he
would like to move to a less restrictive unit and ultimately
out of the institute.

For risk and side effects, Dr. Anderson told Dan that “mood side effects can
happen”; “weight gain … can happen with Risperidone as well as with valproic
acid”; and “sedation that can take place with these medications as well as the
Benztropine and Lorazepam.”

4
No. 2022AP1402

¶7 The doctor testified that prior to the expiration of the involuntary
medication order, Dan had “intermittent periods of declining medication requiring
the intra-muscular back-up injection formulation of the medicine or its
alternative.” Further, she testified that Dan had six seclusion restraint events over
several months; however, when Dan was informed that the involuntary medication
order had expired in early December 2021, he “precipitously stopped taking the
medication so consistently” and he had two seclusion restraint events in one day.
The doctor testified that the only new medications that had been added in the
current petition was escitalopram, which had been prescribed two months earlier.6

¶8 Dr. Anderson testified that when she attempted to discuss
medication with Dan, he would repeatedly state that he takes his medication, but
the doctor stated that he did not demonstrate that he understood that taking the
medication would provide prolonged stability for him. Dr. Anderson stated that
Dan has not complained about side effects, but instead stated that “he’s fine, he’s
not ill, he does not need them.” The doctor testified that if Dan would take his
prescribed medications on a daily basis there would be a positive therapeutic
benefit. Dr. Anderson opined that Dan did not seem to understand that taking his
medication might put him in a position to be moved to a less secure unit.
The doctor testified that Dan’s decision not to cooperate with his medication

6
Later in the proceedings, Dr. Anderson was questioned about Dan’s medications and
the County attorney began to ask about “escitalopram” and Dr. Anderson replied that it was the
generic name for Tylenol. This is factually incorrect. The County offers in appellate briefing that
the doctor misheard the drug name and responded to the beginning of the word, suggesting a
confusion with acetaminophen, the generic form of Tylenol. We form no opinion about what the
doctor believed was stated. However, we note that there is no discussion in the record
specifically addressing acetaminophen or Dan’s use of that medication.

5
No. 2022AP1402

treatment was not based on informed consent because his current medical
conditions affected his ability to do so.

¶9 Dr. Anderson testified that the County requested that the court
authorize injectable formulas of some of the medications—specifically
Haloperidol injectable in place of Risperidone, valproic acid, and Sertraline. The
County also requested the injectable form of Benztropine.7 Dr. Anderson testified
that it was her opinion, held to a reasonable degree of medical certainty, that Dan
was not competent to make choices about psychotropic medications on his own
behalf.

¶10 Ultimately, the circuit court was “satisfied through the testimony of
the doctor that the doctor in fact did explain the advantages, disadvantages, and
side effects and gave that information to [Dan].” The court addressed Dan
directly:

My concern is that you are not at this point competent to
refuse that medication or treatment and that you are at this
point substantially incapable of applying an understanding
of the advantages and disadvantages in order to make that
informed choice as to whether to accept or refuse
medication.

At this point there wasn’t clear testimony that you were
expressing the understanding of the advantages and
disadvantages, and therefore I think it’s reasonable for the
[c]ourt to find that you were incapable of expressing an
understanding of the benefits and the drawbacks of
accepting or rejecting treatment.

7
An issue arose that Benztropine was not included on the medication petition; however
the circuit court concluded that this was a scrivener’s error and that the doctor’s testimony
showed she complied in-person with the statutory mandate to explain the advantages and
disadvantages of this medication with Dan.

6
No. 2022AP1402

The court then made the finding to grant the medication order. The court stated:

He needs treatment and medication. The advantages and
disadvantages and alternatives to that medication have been
explained to him. Due to his mental illness, he is incapable
of expressing an understanding of the advantages and
disadvantages of accepting medication or treatment and the
alternatives. He’s also substantially incapable of applying
an understanding of those. I think it’s more to the second.
It’s not a full second standard, like when we talk about
commitments, but I think as far as my findings go, it is the
substantial incapacity of applying the understanding.

The circuit court entered the order for involuntary medication and treatment on
December 17, 2021. Dan appeals from this order.8

DISCUSSION

¶11 Dan argues that the County failed to offer clear and convincing
evidence to support the circuit court’s involuntary medication order; therefore, the
order should be reversed and vacated. Ultimately, we agree.

¶12 Under the Chapter 51 commitment process, an individual has “the
right to exercise informed consent with regard to all medication and treatment
unless the committing court … makes a determination, following a hearing, that
the individual is not competent to refuse medication or treatment…” WIS. STAT.
§ 51.61(g)(3). In accord with WIS. STAT. § 51.20(13)(e), the County bears the
burden of proving the patient is incompetent to refuse medication by clear and
convincing evidence. Outagamie Cnty. v. Melanie L., 2013 WI 67, ¶37, 349

8
Dan’s notice of appeal reflected an appeal of both the December 3, 2021 order of
commitment and the December 17, 2021 order for involuntary medication and treatment.
However, his appeal focuses solely on the order for medication; therefore, we consider the appeal
of the extension of his commitment to be abandoned.

7
No. 2022AP1402

Wis. 2d 148, 833 N.W.2d 607. “In evaluating whether the County met its burden
of proof, a court must apply facts to the statutory standard” provided in
§ 51.61(1)(g)4. Melanie L., 349 Wis. 2d 148, ¶39. “[T]he circuit court’s findings
of fact are reviewed for clear error, but application of those facts to the statute and
interpretation of the statute are reviewed independently.” Winnebago Cnty. v.
Christopher S., 2016 WI 1, ¶50, 366 Wis. 2d 1, 878 N.W.2d 109.

¶13 In Melanie L., our supreme court reviewed the plain meaning of
WIS. STAT. § 51.61(1)(g)4. It concluded that when the circuit court considers a
petition for involuntary medication of a mentally ill individual under ch. 51, the
first step is to determine whether the petitioning County has presented clear and
convincing evidence that the individual was given a reasonable explanation of the
advantages and disadvantages of and alternatives to accepting a particular
medication or treatment. Id., 349 Wis. 2d 148, ¶67.

The explanation should include why a particular drug is
being prescribed, what the advantages of the drug are
expected to be, what side effects may be anticipated or are
possible, and whether there are reasonable alternatives to
the prescribed medication. The explanation should be
timely, and, ideally, it should be periodically repeated and
reinforced.

Id. As a next step, the petitioning County has two options to proceed to prove
whether the individual is either “incapable of understanding” or “substantially
incapable of expressing an understanding” of the advantages and disadvantages of
accepting or refusing medication. See § 51.61(1)(g)4.a.-b. Our supreme court
explained that “the court’s determination should not turn on the person’s choice to
refuse to take medication; it should turn on the person's ability to process and
apply the information available to the person's own condition before making that
choice.” Melanie L., 349 Wis. 2d 148, ¶78.

8
No. 2022AP1402

¶14 Having considered the proper standard of law, we turn to Dan’s
arguments.9 First, he contends that the court failed to establish the correct burden
of proof and failed to find that the County overcame the presumption that Dan was
competent to make medication decisions. Second, he asserts that the circuit court
failed to find that Dr. Anderson gave a “reasonable” explanation of the
medications and that the County failed to present clear and convincing evidence
that Dr. Anderson gave a reasonable explanation of the disadvantages of the
“particular medications” she prescribed or that Dr. Anderson gave any explanation
of alternatives to the chosen medications.

¶15 We begin with whether the circuit court applied the wrong burden of
proof when it considered the County’s petition. Dan asserts that the record is
devoid of the circuit court’s description of the burden of proof it employed.
Our examination of the record support that while the County argued it satisfied the
clear and convincing standard, the words were not uttered by the circuit court.
The court stated that it had to decide whether Dan “had been informed enough”
and whether he was “capable of making a decision that properly evaluates” the
proposed medications. We are not persuaded that the circuit court’s decision is
erroneous as to the burden of proof, but instead the circuit court errs in its findings
with regard to the reasonableness of the explanation.

9
As a threshold matter, we reject the County’s argument that Dan has waived his
challenge when trial counsel made a statement during the involuntary medication hearing about
not contesting that Dr. Anderson may or may not have orally explained a medication
(Benztropine) but still arguing that the County had failed to provide notice of this medication on
the treatment list in the petition. Our examination of the record does not support a concession by
Dan’s counsel, but an argument differentiating the importance of prior written notice. As Dan
responds, the sufficiency of the evidence may always be appealed. See WIS. STAT. RULE
809.30(2)(h).

9
No. 2022AP1402

¶16 Turning to the inquiry into whether the doctor’s explanation was
reasonable, the record reflects significant gaps in the thoroughness of this
explanation. Dr. Anderson’s testimony was generalized with regard to her
conversations with Dan about the advantages and disadvantages, the alternatives
and side effects of those medications, and his understanding of his illness. It is not
clear in the record that Dr. Anderson complied with Melanie L.’s guidance to
explain to Dan “why a particular drug” was prescribed, the expected advantages
and possible side effects of each medication, or the alternative medication options.
Id., 349 Wis. 2d 148, ¶67. We identify three weaknesses that render the
explanation unreasonable.

¶17 First, we consider the discussion of Haloperidol to be inadequate.
The record reflects that Dr. Anderson did not testify that she explained the
advantages and disadvantages of Haloperidol to Dan, despite relying upon
Haloperidol as the preferred alternative and injectable option for three other drugs.
She did not explain why Dan was prescribed three other medications when one
medication could serve as an acceptable alternative to all three.

¶18 Second, Dr. Anderson’s testimony about escitalopram was
insufficient. The discussion was brief, referencing that it was a treatment for
anxiety. However, the doctor did testify that Dan had only used the medication for
about two months. As a newer medication, there is no record to support that there
has been an ongoing conversation over his multi-year treatment plan to discuss
this medication. Further, she did not discuss why this medication was added into

10
No. 2022AP1402

the medication roster and whether it replaced another medication or responded to a
new symptom.10

¶19 Third, the doctor’s testimony regarding side effects appeared to
minimize this issue. Although the doctor testified that she prescribed Benztropine
as a probable prophylaxis of side effects and stated that Dan had a high risk of
developing side effects because he was also prescribed Risperidone, she failed to
discuss what side effects would be prevented. Further, the doctor did not testify
about any serious side effects to the medication list, but only mentioned mood,
weight gain, and sedation. On appeal Dan references far more serious side effects
to Haloperidol, a point noted by this court in State v. Green, 2021 WI App 18,
¶23, 396 Wis. 2d 658, 957 N.W.2d 583, review granted, 2022 WI 88, and aff’d in
part, 2022 WI 30, 401 Wis. 2d 542, 973 N.W.2d 770.11

¶20 We conclude that the circuit court erred when it concluded that Dr.
Anderson’s explanation was reasonable and that its findings were clearly
10
The doctor’s testimony, through misunderstanding or mishearing, that escitalopram
was a generic form of Tylenol did not make the record stronger on the adequacy of the
explanation.
11
An expert medical witness testified that:

Haldol [also known as Haloperidol] certainly can cause side
effects, including sedation, slurred speech, a tremor, a feeling of
muscle restlessness that we refer to as akathisia, a phenomenon
that is certainly like tremors but referred to as parkinsonism
because it mimics the appearance of individuals who have
Parkinson’s disease. It has the potential to affect cardiac
conduction and heart rhythm. It has an impact on what’s called
the QT interval, which is part of the electrocardiograph rhythm,
and it can certainly have some metabolic side effects as well in
terms of its impacts on weight gain and blood sugar.

State v. Green, 2021 WI App 18, ¶23, 396 Wis. 2d 658, 957 N.W.2d 583, review granted, 2022
WI 88, and aff’d in part, 2022 WI 30, 401 Wis. 2d 542, 973 N.W.2d 770.

11
No. 2022AP1402

erroneous to reach that conclusion. In Melanie L., our supreme court reversed an
involuntary medication order because the record was unclear whether the medical
expert was “applying” the statutory standard or “changing” it. Melanie L., 349
Wis. 2d 148, ¶91. That holding made clear the importance of having testimony
hew to the statutory standard. In Christopher S., our supreme court affirmed an
involuntary medication order in which the doctor’s testimony was brief, but
mirrored the statutory language. However, we do not read Christophe S. to negate
a need to provide a careful analysis in the totality of circumstances of the record
before the circuit court.12 The Christopher S. court expressly stated that Melanie
L. was instructive and relied upon its holdings to distinguish Christopher S.’s
situation. Christopher S., 366 Wis. 2d 1, ¶51.

12
Our supreme court distinguished Winnebago Cnty. v. Christopher S., 2016 WI 1, ¶54,
366 Wis. 2d 1, 878 N.W.2d 109 from Outagamie Cnty. v. Melanie L., 2013 WI 67, ¶37, 349
Wis. 2d 148, 833 N.W.2d 607, on the basis that the medical expert’s testimony mirrored statutory
language. The exchange provided was:

Q. Dr. Keshena, in the course of your treatment of [Christopher]
have you had an opportunity to explain to him the advantages,
disadvantages, and alternatives to the medication?

A. Yes.

Q. And after you’ve done that, in your opinion would he be
substantially incapable or substantially capable of applying an
understanding of the advantages, disadvantages, and alternatives
to his own conditions in order to make an informed choice as to
whether to accept or refuse psychotropic medication?

A. He’s not capable.

Q. So you’re saying he’s substantially incapable?

A. Yes.

Christopher S., 366 Wis. 2d 1, ¶54. In contrast, in Melanie L., the doctor’s testimony focused on
whether Melanie L was “capable of applying an understanding of the medication ‘to her
advantage,’” which left it unclear what standard the doctor applied. Id., 349 Wis. 2d 148, ¶91.

12
No. 2022AP1402

¶21 Although there are similarities in the testimony here with
Christopher S., including that the doctor was asked questions that mirror statutory
language, there are distinctions that warrant a different outcome. First, in
Christopher S., the medication petition was heard in the same hearing as the
recommitment petition. It was noted in that case that there was “ample evidence
that the doctors who treated Christopher S. explained the advantages,
disadvantages, and alternatives to medication to him. The trial judge was familiar
with this evidence.” Id., 366 Wis. 2d 1, ¶95 (S. Abrahamson, J., concurring). In
contrast here, the hearings on the recommitment and the medication petitions were
heard two weeks apart by different judges.

¶22 Second, in Christopher S., our supreme court noted that the
testifying doctor’s “report also tracked the statutory language.” Id., 366 Wis. 2d
1, ¶55. Our review of the record here shows that the doctor’s report was not
discussed in any detail during the hearing. Our review of the report shows it
tracks the statutory language when it discussed involuntary medication and Dan’s
competence to refuse that medication. However, the report does not provide any
greater detail into the doctor’s efforts to explain the “particular” prescribed
medications to Dan.

¶23 Christopher S. did not overrule Melanie L.; furthermore, that
decision did not reduce a petitioning county’s burden of proof. Our supreme court
provided that for a county to satisfy the requirements of WIS. STAT.
§ 51.61(1)(g)4., the involuntary medication “hearings cannot be perfunctory under
the law. Attention to detail is important.” Melanie L., 349 Wis. 2d 148, ¶94.
It reminded the petitioner counties not to expect that the circuit court in a
chapter 51 proceeding “will automatically approve an involuntary medication
order, even though the person before the court has chosen a course of action that

13
No. 2022AP1402

the county disapproves.” Id. It is under this reasoning that the circuit court’s
order cannot stand because the testimony elicited at this hearing was generalized
and perfunctory.

¶24 We conclude that the County failed to prove by clear and convincing
evidence that Dan was given a reasonable explanation of his medications,
including disadvantages of the “particular medications” she prescribed or any
explanation of alternatives to the chosen medications. Dr. Anderson’s testimony
regarding Dan’s prescribed medications and her recitation of facts did not show
that Dan was given a reasonable explanation. Dr. Anderson’s testimony did not
address the advantages, disadvantages, and side effects of two of the medications,
Haloperidol and escitalopram, in an adequate manner.

CONCLUSION

¶25 We reverse the circuit court. We conclude that the County failed to
prove that Dan was given a reasonable explanation of the advantages,
disadvantages, and alternatives to his prescribed medications for his mental illness
in order to make an informed choice as to whether to accept or refuse the
medication. Without the County proving that a reasonable explanation was given
to Dan, we further conclude that the County has not shown by clear and
convincing evidence that Dan was “substantially incapable of applying” or
“incapable of expressing” an understanding of those matters. The County did not
overcome Dan’s presumption of competence to make an informed choice to refuse
medication. See Melanie L., 349 Wis. 2d 148, ¶96. Accordingly, we remand this

14
No. 2022AP1402

case to the circuit court with directions to vacate the order for involuntary
medication and treatment.13

By the Court.—Order reversed and cause remanded with directions.

This opinion will not be published. See WIS. STAT. RULE
809.23(1)(b)4.

13
Although it has been established that the reversal of a commitment order does not
require remand when the circuit court has lost competency to proceed, Dan’s commitment order
was not reversed. See Sheboygan Cnty. v. M.W., 2022 WI 40, ¶36, 402 Wis. 2d 1, 974 N.W.2d
733. Therefore, we remand with directions to vacate the medication order.

15